Cavity Environmental Control System Upgrade for NASA’s Stratospheric Observatory for Infrared Astronomy

The main goal of this project is to fulfill the need of a controller upgrade for the Cavity Environmental Control System (CECS) on NASA’s Stratospheric Observatory for Infrared Astronomy (SOFIA) aircraft. The preceding controller had multiple disadvantages including operating in an unpressurized region, incomplete functionality implementation, limited fault and status monitoring capability, and reduced maintainability and reliability. The new controller will go through the NASA design process to fulfill all the requirements of CECS operation including complete functionality of all devices currently installed on the aircraft, added devices to improve fault and health monitoring, and overall improvement in maintainability and reliability

Evaluation of Surveillance Methods for Staphylococcal Toxic Shock Syndrome

We compared passive surveillance and International Classification of Diseases, 9th Revision, codes for completeness of staphylococcal toxic shock syndrome (TSS) surveillance in the Minneapolis–St. Paul area, Minnesota, USA. TSS-specific codes identified 55% of cases compared with 30% by passive surveillance and were more sensitive (p = 0.0005, McNemar χ2 12.25)

Flexural and Shear Capacities of Reinforced Concrete Beams with Volcanic Tuff

An experimental investigation was carried out to study the effect of volcanic tuff (V.T.), as a fine aggregate on the flexural and shear capacities of reinforced concrete beams. Three different types of volcanic tuff which is a local material that is available at different locations in Jordan (known as yellow, gray and brown volcanic tuff) were used in this study. Four grades of concrete compressive strengths (20, 30, 40 and 50 MPa) are also used. The experimental program consisted of testing 64 beams (16 beams with 0% of volcanic tuff and 16 beams with 20% volcanic tuff as a fine aggregate for each type of volcanic tuff). The analysis showed that replacing the fine aggregate by 20% volcanic tuff will improve the flexural and shear capacities of the reinforced concrete beams by 6% to 16% for brown tuff, 3% to 8% for gray tuff and 10 % to 26 % for yellow tuff for the four concrete strength grades.Key Words: Pozzolan (Volcanic tuff), flexural and shear capacities, Reinforced concrete beam

Influence of host genetics on the severity of coccidioidomycosis.

Coccidioidomycosis, a mild flulike illness in approximately 40% of infected persons, progresses to severe pulmonary or disseminated disease in 1% to 10% of symptomatic cases. We examined host genetic influences on disease severity among class II HLA loci and the ABO blood group. Participants included African-American, Caucasian, and Hispanic persons with mild or severe disseminated coccidioidomycosis from Kern County, California. Among Hispanics, predisposition to symptomatic disease and severe disseminated disease is associated with blood types A and B, respectively. The HLA class II DRB1*1301 allele marks a pre-disposition to severe disseminated disease in each of the three groups. Reduced risk for severe disease is associated with DRB1*0301-DQB1*0201 among Caucasians and Hispanics and with DRB1*1501-DQB1*0602 among African-Americans. These data support the hypothesis that host genes, in particular HLA class II and the ABO blood group, influence susceptibility to severe coccidioidomycosis

Candida dubliniensis fungemia: the first four cases in North America.

We report the first four North American cases of Candida dubliniensis fungemia, including the first isolation of this organism from the bloodstream of an HIV-infected person. All isolates were susceptible in vitro to commonly used antifungal drugs. This report demonstrates that C. dubliniensis can cause bloodstream infection; however, the incidence of disease is not known

Global use of Haemophilus influenzae type b conjugate vaccine.

Haemophilus influenzae type b (Hib) conjugate vaccines have been underutilized globally. We report progress in global use of Hib vaccines included in national immunization schedules. The number of countries using Hib vaccine increased from 89/193 (46%) in 2004 to 158/193 (82%) by the end of 2009. The increase was greatest among low-income countries eligible for financial support from the GAVI Alliance [13/75 (17%) in 2004, 60/72 (83%) by the end of 2009], and can be attributed to various factors. Additional efforts are still needed to increase vaccine adoption in lower middle income countries [20/31 (65%) by the end of 2009]

Case-control vaccine effectiveness studies: Preparation, design, and enrollment of cases and control

Case-control studies are commonly used to evaluate effectiveness of licensed vaccines after deployment in public health programs. Such studies can provide policy-relevant data on vaccine performance under \u27real world\u27 conditions, contributing to the evidence base to support and sustain introduction of new vaccines. However, case-control studies do not measure the impact of vaccine introduction on disease at a population level, and are subject to bias and confounding, which may lead to inaccurate results that can misinform policy decisions. In 2012, a group of experts met to review recent experience with case-control studies evaluating the effectiveness of several vaccines; here we summarize the recommendations of that group regarding best practices for planning, design and enrollment of cases and controls. Rigorous planning and preparation should focus on understanding the study context including healthcare-seeking and vaccination practices. Case-control vaccine effectiveness studies are best carried out soon after vaccine introduction because high coverage creates strong potential for confounding. Endpoints specific to the vaccine target are preferable to non-specific clinical syndromes since the proportion of non-specific outcomes preventable through vaccination may vary over time and place, leading to potentially confusing results. Controls should be representative of the source population from which cases arise, and are generally recruited from the community or health facilities where cases are enrolled. Matching of controls to cases for potential confounding factors is commonly used, although should be reserved for a limited number of key variables believed to be linked to both vaccination and disease. Case-control vaccine effectiveness studies can provide information useful to guide policy decisions and vaccine development, however rigorous preparation and design is essential